nodes	percent_of_prediction	percent_of_DWPC	metapath
Vilazodone—CYP2C18—malignant glioma	0.877	1	CbGaD
Vilazodone—CYP3A4—Temozolomide—malignant glioma	0.0445	1	CbGbCtD
Vilazodone—HTR1A—telencephalic ventricle—malignant glioma	0.00283	0.163	CbGeAlD
Vilazodone—DRD2—telencephalic ventricle—malignant glioma	0.00256	0.148	CbGeAlD
Vilazodone—SLC6A4—brainstem—malignant glioma	0.000863	0.0498	CbGeAlD
Vilazodone—HTR1A—brainstem—malignant glioma	0.000767	0.0442	CbGeAlD
Vilazodone—SLC6A4—telencephalon—malignant glioma	0.000766	0.0442	CbGeAlD
Vilazodone—DRD2—brainstem—malignant glioma	0.000693	0.0399	CbGeAlD
Vilazodone—HTR1A—telencephalon—malignant glioma	0.00068	0.0392	CbGeAlD
Vilazodone—DRD2—retina—malignant glioma	0.000668	0.0385	CbGeAlD
Vilazodone—Dry eye—Temozolomide—malignant glioma	0.00062	0.0397	CcSEcCtD
Vilazodone—DRD2—telencephalon—malignant glioma	0.000615	0.0355	CbGeAlD
Vilazodone—SLC6A4—midbrain—malignant glioma	0.00055	0.0317	CbGeAlD
Vilazodone—Gastroenteritis—Temozolomide—malignant glioma	0.00055	0.0352	CcSEcCtD
Vilazodone—SLC6A4—spinal cord—malignant glioma	0.000537	0.031	CbGeAlD
Vilazodone—Hyponatraemia—Carmustine—malignant glioma	0.000506	0.0324	CcSEcCtD
Vilazodone—HTR1A—midbrain—malignant glioma	0.000489	0.0282	CbGeAlD
Vilazodone—HTR1A—spinal cord—malignant glioma	0.000477	0.0275	CbGeAlD
Vilazodone—DRD2—midbrain—malignant glioma	0.000441	0.0255	CbGeAlD
Vilazodone—Breast disorder—Temozolomide—malignant glioma	0.000441	0.0282	CcSEcCtD
Vilazodone—SLC6A4—central nervous system—malignant glioma	0.000435	0.0251	CbGeAlD
Vilazodone—CYP2D6—brainstem—malignant glioma	0.000416	0.024	CbGeAlD
Vilazodone—Pollakiuria—Temozolomide—malignant glioma	0.000389	0.0249	CcSEcCtD
Vilazodone—Erectile dysfunction—Temozolomide—malignant glioma	0.000388	0.0249	CcSEcCtD
Vilazodone—HTR1A—central nervous system—malignant glioma	0.000387	0.0223	CbGeAlD
Vilazodone—HTR1A—cerebellum—malignant glioma	0.000378	0.0218	CbGeAlD
Vilazodone—CYP2D6—telencephalon—malignant glioma	0.000369	0.0213	CbGeAlD
Vilazodone—DRD2—central nervous system—malignant glioma	0.000349	0.0202	CbGeAlD
Vilazodone—Hallucination—Carmustine—malignant glioma	0.000347	0.0222	CcSEcCtD
Vilazodone—SLC6A4—brain—malignant glioma	0.000346	0.0199	CbGeAlD
Vilazodone—Connective tissue disorder—Carmustine—malignant glioma	0.000343	0.022	CcSEcCtD
Vilazodone—DRD2—cerebellum—malignant glioma	0.000341	0.0197	CbGeAlD
Vilazodone—Hallucination—Temozolomide—malignant glioma	0.000336	0.0215	CcSEcCtD
Vilazodone—Connective tissue disorder—Temozolomide—malignant glioma	0.000331	0.0212	CcSEcCtD
Vilazodone—Eye disorder—Carmustine—malignant glioma	0.000326	0.0209	CcSEcCtD
Vilazodone—Eye disorder—Temozolomide—malignant glioma	0.000315	0.0202	CcSEcCtD
Vilazodone—Cardiac disorder—Temozolomide—malignant glioma	0.000313	0.0201	CcSEcCtD
Vilazodone—HTR1A—brain—malignant glioma	0.000307	0.0177	CbGeAlD
Vilazodone—Mental disorder—Carmustine—malignant glioma	0.000306	0.0196	CcSEcCtD
Vilazodone—Malnutrition—Carmustine—malignant glioma	0.000304	0.0195	CcSEcCtD
Vilazodone—Mental disorder—Temozolomide—malignant glioma	0.000295	0.0189	CcSEcCtD
Vilazodone—Malnutrition—Temozolomide—malignant glioma	0.000294	0.0188	CcSEcCtD
Vilazodone—Dysgeusia—Temozolomide—malignant glioma	0.000288	0.0184	CcSEcCtD
Vilazodone—Vision blurred—Carmustine—malignant glioma	0.000286	0.0183	CcSEcCtD
Vilazodone—Tremor—Carmustine—malignant glioma	0.000285	0.0182	CcSEcCtD
Vilazodone—Agitation—Carmustine—malignant glioma	0.000279	0.0179	CcSEcCtD
Vilazodone—DRD2—brain—malignant glioma	0.000277	0.016	CbGeAlD
Vilazodone—Vision blurred—Temozolomide—malignant glioma	0.000277	0.0177	CcSEcCtD
Vilazodone—Tremor—Temozolomide—malignant glioma	0.000275	0.0176	CcSEcCtD
Vilazodone—Agitation—Temozolomide—malignant glioma	0.00027	0.0173	CcSEcCtD
Vilazodone—Convulsion—Carmustine—malignant glioma	0.000263	0.0169	CcSEcCtD
Vilazodone—Palpitations—Temozolomide—malignant glioma	0.000259	0.0166	CcSEcCtD
Vilazodone—Convulsion—Temozolomide—malignant glioma	0.000254	0.0163	CcSEcCtD
Vilazodone—Arthralgia—Temozolomide—malignant glioma	0.00025	0.016	CcSEcCtD
Vilazodone—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.000248	0.0159	CcSEcCtD
Vilazodone—Dry mouth—Temozolomide—malignant glioma	0.000244	0.0157	CcSEcCtD
Vilazodone—Nervous system disorder—Temozolomide—malignant glioma	0.000235	0.0151	CcSEcCtD
Vilazodone—Skin disorder—Temozolomide—malignant glioma	0.000233	0.0149	CcSEcCtD
Vilazodone—Hyperhidrosis—Temozolomide—malignant glioma	0.000232	0.0148	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.000226	0.0145	CcSEcCtD
Vilazodone—Insomnia—Carmustine—malignant glioma	0.000224	0.0144	CcSEcCtD
Vilazodone—Paraesthesia—Carmustine—malignant glioma	0.000223	0.0143	CcSEcCtD
Vilazodone—Somnolence—Carmustine—malignant glioma	0.00022	0.0141	CcSEcCtD
Vilazodone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.000218	0.014	CcSEcCtD
Vilazodone—Insomnia—Temozolomide—malignant glioma	0.000217	0.0139	CcSEcCtD
Vilazodone—Decreased appetite—Carmustine—malignant glioma	0.000216	0.0138	CcSEcCtD
Vilazodone—Paraesthesia—Temozolomide—malignant glioma	0.000215	0.0138	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Carmustine—malignant glioma	0.000214	0.0137	CcSEcCtD
Vilazodone—CYP3A4—central nervous system—malignant glioma	0.000213	0.0123	CbGeAlD
Vilazodone—Somnolence—Temozolomide—malignant glioma	0.000213	0.0136	CcSEcCtD
Vilazodone—Dyspepsia—Temozolomide—malignant glioma	0.000211	0.0135	CcSEcCtD
Vilazodone—CYP2D6—central nervous system—malignant glioma	0.00021	0.0121	CbGeAlD
Vilazodone—Decreased appetite—Temozolomide—malignant glioma	0.000208	0.0133	CcSEcCtD
Vilazodone—Gastrointestinal disorder—Temozolomide—malignant glioma	0.000207	0.0133	CcSEcCtD
Vilazodone—Fatigue—Temozolomide—malignant glioma	0.000207	0.0132	CcSEcCtD
Vilazodone—CYP2D6—cerebellum—malignant glioma	0.000205	0.0118	CbGeAlD
Vilazodone—Feeling abnormal—Carmustine—malignant glioma	0.000204	0.0131	CcSEcCtD
Vilazodone—Feeling abnormal—Temozolomide—malignant glioma	0.000197	0.0126	CcSEcCtD
Vilazodone—Asthenia—Carmustine—malignant glioma	0.000178	0.0114	CcSEcCtD
Vilazodone—Asthenia—Temozolomide—malignant glioma	0.000172	0.011	CcSEcCtD
Vilazodone—Diarrhoea—Carmustine—malignant glioma	0.00017	0.0109	CcSEcCtD
Vilazodone—CYP2D6—brain—malignant glioma	0.000167	0.00961	CbGeAlD
Vilazodone—Dizziness—Carmustine—malignant glioma	0.000164	0.0105	CcSEcCtD
Vilazodone—Diarrhoea—Temozolomide—malignant glioma	0.000164	0.0105	CcSEcCtD
Vilazodone—Dizziness—Temozolomide—malignant glioma	0.000158	0.0102	CcSEcCtD
Vilazodone—Vomiting—Carmustine—malignant glioma	0.000158	0.0101	CcSEcCtD
Vilazodone—Vomiting—Temozolomide—malignant glioma	0.000152	0.00976	CcSEcCtD
Vilazodone—Nausea—Carmustine—malignant glioma	0.000147	0.00943	CcSEcCtD
Vilazodone—Nausea—Temozolomide—malignant glioma	0.000142	0.00912	CcSEcCtD
Vilazodone—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	3.16e-05	0.0007	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCR3—malignant glioma	3.15e-05	0.000698	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DTX1—malignant glioma	3.13e-05	0.000693	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—COX8A—malignant glioma	3.02e-05	0.000669	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—F2—malignant glioma	2.99e-05	0.000664	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—KNG1—malignant glioma	2.98e-05	0.000662	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—BDKRB2—malignant glioma	2.98e-05	0.00066	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—BDKRB2—malignant glioma	2.88e-05	0.000638	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCR3—malignant glioma	2.86e-05	0.000634	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SUFU—malignant glioma	2.83e-05	0.000627	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HEY2—malignant glioma	2.79e-05	0.00062	CbGpPWpGaD
Vilazodone—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	2.77e-05	0.000615	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—GFAP—malignant glioma	2.73e-05	0.000605	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KNG1—malignant glioma	2.71e-05	0.000601	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SPHK1—malignant glioma	2.64e-05	0.000586	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—KNG1—malignant glioma	2.62e-05	0.000581	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—BDKRB2—malignant glioma	2.61e-05	0.00058	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—GSTP1—malignant glioma	2.6e-05	0.000577	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CCR4—malignant glioma	2.59e-05	0.000574	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HEY1—malignant glioma	2.59e-05	0.000574	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—ASMT—malignant glioma	2.56e-05	0.000569	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAT—malignant glioma	2.53e-05	0.000561	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HIST1H3B—malignant glioma	2.51e-05	0.000557	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SUFU—malignant glioma	2.48e-05	0.000551	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HEY2—malignant glioma	2.45e-05	0.000544	CbGpPWpGaD
Vilazodone—DRD2—Circadian rythm related genes—TP53—malignant glioma	2.42e-05	0.000538	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—BCAN—malignant glioma	2.41e-05	0.000535	CbGpPWpGaD
Vilazodone—HTR1A—GPCR ligand binding—CXCL8—malignant glioma	2.4e-05	0.000533	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—MMP3—malignant glioma	2.4e-05	0.000532	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—GFAP—malignant glioma	2.4e-05	0.000531	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—NCOR1—malignant glioma	2.39e-05	0.00053	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KNG1—malignant glioma	2.38e-05	0.000527	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SPHK1—malignant glioma	2.32e-05	0.000514	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JAG2—malignant glioma	2.29e-05	0.000509	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HEY1—malignant glioma	2.27e-05	0.000504	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CCR4—malignant glioma	2.27e-05	0.000504	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HIST1H3B—malignant glioma	2.21e-05	0.000489	CbGpPWpGaD
Vilazodone—DRD2—GPCR ligand binding—CXCL8—malignant glioma	2.11e-05	0.000468	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—MMP3—malignant glioma	2.11e-05	0.000467	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JAG2—malignant glioma	2.01e-05	0.000447	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—COX8A—malignant glioma	1.97e-05	0.000437	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—CAV1—malignant glioma	1.95e-05	0.000432	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—IDH2—malignant glioma	1.94e-05	0.000431	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—H3F3A—malignant glioma	1.94e-05	0.000431	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—F2—malignant glioma	1.93e-05	0.000428	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCR3—malignant glioma	1.92e-05	0.000426	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—YWHAE—malignant glioma	1.87e-05	0.000415	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK2—malignant glioma	1.87e-05	0.000415	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FLT1—malignant glioma	1.86e-05	0.000413	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—DUSP6—malignant glioma	1.85e-05	0.000411	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CG—malignant glioma	1.84e-05	0.000409	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—JAG1—malignant glioma	1.83e-05	0.000406	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2B6—malignant glioma	1.83e-05	0.000405	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH3—malignant glioma	1.82e-05	0.000404	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FBXW7—malignant glioma	1.79e-05	0.000398	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CG—malignant glioma	1.77e-05	0.000393	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BDKRB2—malignant glioma	1.76e-05	0.00039	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—F2—malignant glioma	1.75e-05	0.000388	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PPARG—malignant glioma	1.71e-05	0.00038	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—H3F3A—malignant glioma	1.7e-05	0.000378	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—F2—malignant glioma	1.69e-05	0.000375	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCR3—malignant glioma	1.69e-05	0.000374	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT2—malignant glioma	1.69e-05	0.000374	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—ASMT—malignant glioma	1.68e-05	0.000372	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CG—malignant glioma	1.67e-05	0.000372	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—IDH1—malignant glioma	1.67e-05	0.000371	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PTPN11—malignant glioma	1.65e-05	0.000365	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—YWHAE—malignant glioma	1.64e-05	0.000364	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK2—malignant glioma	1.64e-05	0.000364	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FLT1—malignant glioma	1.63e-05	0.000363	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH2—malignant glioma	1.63e-05	0.000363	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—DUSP6—malignant glioma	1.63e-05	0.000361	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CD—malignant glioma	1.62e-05	0.00036	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CG—malignant glioma	1.62e-05	0.000359	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SPHK1—malignant glioma	1.62e-05	0.000359	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—JAG1—malignant glioma	1.61e-05	0.000356	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH3—malignant glioma	1.6e-05	0.000355	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KNG1—malignant glioma	1.6e-05	0.000355	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CYP2C18—malignant glioma	1.58e-05	0.000351	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BCAN—malignant glioma	1.58e-05	0.00035	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FBXW7—malignant glioma	1.57e-05	0.000349	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CD—malignant glioma	1.56e-05	0.000346	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BDKRB2—malignant glioma	1.54e-05	0.000342	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—F2—malignant glioma	1.54e-05	0.000341	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT2—malignant glioma	1.53e-05	0.00034	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NTRK1—malignant glioma	1.52e-05	0.000338	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT2—malignant glioma	1.48e-05	0.000329	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CD—malignant glioma	1.47e-05	0.000327	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CG—malignant glioma	1.47e-05	0.000326	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PTPN11—malignant glioma	1.44e-05	0.000321	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH2—malignant glioma	1.44e-05	0.000318	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CD—malignant glioma	1.42e-05	0.000316	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP3—malignant glioma	1.42e-05	0.000314	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	1.41e-05	0.000314	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	1.4e-05	0.000312	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KNG1—malignant glioma	1.4e-05	0.000312	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTK2—malignant glioma	1.36e-05	0.000303	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CB—malignant glioma	1.36e-05	0.000301	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	1.36e-05	0.000301	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTGS2—malignant glioma	1.35e-05	0.000299	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT2—malignant glioma	1.35e-05	0.000299	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HES1—malignant glioma	1.34e-05	0.000297	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NTRK1—malignant glioma	1.34e-05	0.000297	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NCOR1—malignant glioma	1.33e-05	0.000296	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—RAF1—malignant glioma	1.31e-05	0.000292	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—IL2—malignant glioma	1.3e-05	0.000288	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CD—malignant glioma	1.29e-05	0.000287	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	1.28e-05	0.000285	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTT1—malignant glioma	1.28e-05	0.000284	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	1.28e-05	0.000283	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IDH2—malignant glioma	1.27e-05	0.000282	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP3—malignant glioma	1.24e-05	0.000276	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CB—malignant glioma	1.24e-05	0.000275	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—SPP1—malignant glioma	1.24e-05	0.000275	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CDKN2B—malignant glioma	1.23e-05	0.000274	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	1.23e-05	0.000274	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS1—malignant glioma	1.2e-05	0.000266	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTK2—malignant glioma	1.2e-05	0.000266	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.19e-05	0.000265	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—CXCL8—malignant glioma	1.19e-05	0.000265	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—IL2—malignant glioma	1.18e-05	0.000261	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HES1—malignant glioma	1.18e-05	0.000261	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TERT—malignant glioma	1.17e-05	0.000261	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PTEN—malignant glioma	1.17e-05	0.000261	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NCOR1—malignant glioma	1.17e-05	0.00026	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—RAF1—malignant glioma	1.15e-05	0.000256	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PDGFB—malignant glioma	1.15e-05	0.000254	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGFR1—malignant glioma	1.14e-05	0.000253	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—IL2—malignant glioma	1.14e-05	0.000253	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CB—malignant glioma	1.13e-05	0.00025	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—HIF1A—malignant glioma	1.12e-05	0.000249	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFRA—malignant glioma	1.12e-05	0.000249	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—BCHE—malignant glioma	1.12e-05	0.000248	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—SLC5A5—malignant glioma	1.1e-05	0.000245	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—IDH1—malignant glioma	1.09e-05	0.000242	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—SPP1—malignant glioma	1.09e-05	0.000241	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CAV1—malignant glioma	1.09e-05	0.000241	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—CXCL8—malignant glioma	1.08e-05	0.00024	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KDR—malignant glioma	1.07e-05	0.000238	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SPHK1—malignant glioma	1.06e-05	0.000235	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.04e-05	0.00023	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—IL2—malignant glioma	1.03e-05	0.00023	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—F2—malignant glioma	1.03e-05	0.000229	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FN1—malignant glioma	1.03e-05	0.000229	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TERT—malignant glioma	1.03e-05	0.000229	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BAD—malignant glioma	1.02e-05	0.000227	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	1.01e-05	0.000224	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PDGFB—malignant glioma	1.01e-05	0.000223	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGFR1—malignant glioma	1e-05	0.000222	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CD80—malignant glioma	9.91e-06	0.00022	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	9.89e-06	0.00022	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—APC—malignant glioma	9.89e-06	0.00022	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—HIF1A—malignant glioma	9.86e-06	0.000219	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGF—malignant glioma	9.78e-06	0.000217	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTPN11—malignant glioma	9.72e-06	0.000216	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CAV1—malignant glioma	9.54e-06	0.000212	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KDR—malignant glioma	9.43e-06	0.000209	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—BRAF—malignant glioma	9.3e-06	0.000206	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—F2—malignant glioma	9.08e-06	0.000201	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FN1—malignant glioma	9.08e-06	0.000201	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT2—malignant glioma	9.05e-06	0.000201	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—EGFR—malignant glioma	9.01e-06	0.0002	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BAD—malignant glioma	8.97e-06	0.000199	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—NOTCH1—malignant glioma	8.88e-06	0.000197	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—GSTP1—malignant glioma	8.88e-06	0.000197	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CD80—malignant glioma	8.7e-06	0.000193	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	8.7e-06	0.000193	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CG—malignant glioma	8.69e-06	0.000193	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—APC—malignant glioma	8.69e-06	0.000193	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAT—malignant glioma	8.64e-06	0.000192	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	8.62e-06	0.000191	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGF—malignant glioma	8.59e-06	0.000191	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTPN11—malignant glioma	8.53e-06	0.000189	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—KRAS—malignant glioma	8.52e-06	0.000189	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTT1—malignant glioma	8.38e-06	0.000186	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—FGF2—malignant glioma	8.33e-06	0.000185	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—PIK3CA—malignant glioma	8.28e-06	0.000184	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—BRAF—malignant glioma	8.17e-06	0.000181	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—NCOR1—malignant glioma	8.16e-06	0.000181	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT2—malignant glioma	7.95e-06	0.000176	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—EGFR—malignant glioma	7.91e-06	0.000176	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS1—malignant glioma	7.85e-06	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	7.82e-06	0.000174	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MDM2—malignant glioma	7.79e-06	0.000173	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—RAF1—malignant glioma	7.77e-06	0.000172	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—ERBB2—malignant glioma	7.68e-06	0.00017	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CD—malignant glioma	7.64e-06	0.000169	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	7.58e-06	0.000168	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—PIK3CA—malignant glioma	7.56e-06	0.000168	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—KRAS—malignant glioma	7.48e-06	0.000166	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—FGF2—malignant glioma	7.31e-06	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—BCHE—malignant glioma	7.3e-06	0.000162	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CXCL8—malignant glioma	7.29e-06	0.000162	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—SLC5A5—malignant glioma	7.21e-06	0.00016	CbGpPWpGaD
Vilazodone—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	7.04e-06	0.000156	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—CASP3—malignant glioma	6.97e-06	0.000155	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—IL2—malignant glioma	6.96e-06	0.000154	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—PIK3CA—malignant glioma	6.87e-06	0.000152	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MDM2—malignant glioma	6.84e-06	0.000152	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—RAF1—malignant glioma	6.82e-06	0.000151	CbGpPWpGaD
Vilazodone—CYP2C18—Metabolism—AKT1—malignant glioma	6.77e-06	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—ERBB2—malignant glioma	6.75e-06	0.00015	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CB—malignant glioma	6.66e-06	0.000148	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—CAV1—malignant glioma	6.65e-06	0.000148	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MMP9—malignant glioma	6.59e-06	0.000146	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PTEN—malignant glioma	6.55e-06	0.000145	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CXCL8—malignant glioma	6.4e-06	0.000142	CbGpPWpGaD
Vilazodone—HTR1A—Signaling by GPCR—AKT1—malignant glioma	6.39e-06	0.000142	CbGpPWpGaD
Vilazodone—DRD2—GPCR downstream signaling—AKT1—malignant glioma	6.18e-06	0.000137	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—CASP3—malignant glioma	6.12e-06	0.000136	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—IL2—malignant glioma	6.11e-06	0.000136	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CG—malignant glioma	6.06e-06	0.000134	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—VEGFA—malignant glioma	5.92e-06	0.000131	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—STAT3—malignant glioma	5.86e-06	0.00013	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PPARG—malignant glioma	5.85e-06	0.00013	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—GSTP1—malignant glioma	5.81e-06	0.000129	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MMP9—malignant glioma	5.79e-06	0.000128	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PTEN—malignant glioma	5.75e-06	0.000128	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAT—malignant glioma	5.65e-06	0.000125	CbGpPWpGaD
Vilazodone—DRD2—Signaling by GPCR—AKT1—malignant glioma	5.61e-06	0.000124	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—MYC—malignant glioma	5.44e-06	0.000121	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—NCOR1—malignant glioma	5.34e-06	0.000118	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CD—malignant glioma	5.33e-06	0.000118	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—EGFR—malignant glioma	5.33e-06	0.000118	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—VEGFA—malignant glioma	5.2e-06	0.000115	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—STAT3—malignant glioma	5.14e-06	0.000114	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—KRAS—malignant glioma	5.03e-06	0.000112	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—MYC—malignant glioma	4.78e-06	0.000106	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—EGFR—malignant glioma	4.68e-06	0.000104	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CB—malignant glioma	4.64e-06	0.000103	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	4.62e-06	0.000103	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTGS2—malignant glioma	4.6e-06	0.000102	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—TP53—malignant glioma	4.47e-06	9.92e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—KRAS—malignant glioma	4.42e-06	9.8e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—CAV1—malignant glioma	4.35e-06	9.65e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—PIK3CA—malignant glioma	4.06e-06	9e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PTEN—malignant glioma	4.01e-06	8.9e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CG—malignant glioma	3.96e-06	8.79e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—TP53—malignant glioma	3.93e-06	8.71e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PPARG—malignant glioma	3.82e-06	8.48e-05	CbGpPWpGaD
Vilazodone—HTR1A—Signaling Pathways—AKT1—malignant glioma	3.78e-06	8.38e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CD—malignant glioma	3.48e-06	7.73e-05	CbGpPWpGaD
Vilazodone—DRD2—Signaling Pathways—AKT1—malignant glioma	3.31e-06	7.35e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.04e-06	6.74e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTGS2—malignant glioma	3.01e-06	6.67e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—PIK3CA—malignant glioma	2.83e-06	6.28e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PTEN—malignant glioma	2.62e-06	5.82e-05	CbGpPWpGaD
Vilazodone—CYP2D6—Metabolism—AKT1—malignant glioma	2.31e-06	5.13e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—PIK3CA—malignant glioma	1.85e-06	4.11e-05	CbGpPWpGaD
Vilazodone—CYP3A4—Metabolism—AKT1—malignant glioma	1.51e-06	3.35e-05	CbGpPWpGaD
